Want to join the conversation?
$ALXN 2Q15 Call: In Japan, ALXN received regulatory approval for Strensiq as a treatment for patients with HPP. The youngest HPP patients treated with Strensiq had an 84% overall survival. Working with Japanese healthcare authorities to make this breakthrough therapy available to patients as quickly as possible.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?